Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals ($APLS), sold shares on the open market three times in the last year, totaling about $175 thousand. Her most recent sale occurred on January 22, 2026. These sales rank her 8,713th among nearly 12,000 individual insiders by value sold, well below the average of $8.6 million across about six transactions per insider. She made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | S | Common Stock | 2797 | $21.77 | 86,527.0000 | 130,067,000 | 3.13% | 0.00% |
| Jan. 20, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | S | Common Stock | 1882 | $19.79 | 89,324.0000 | 130,067,000 | 2.06% | 0.00% |
| Jan. 5, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | S | Common Stock | 3020 | $25.53 | 91,206.0000 | 130,067,000 | 3.21% | 0.00% |
| June 9, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| Jan. 21, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | A | Common Stock | 39594 | $0.00 | 93,301.3700 | 123,905,000 | 73.72% | 0.03% |
| Jan. 17, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | S | Common Stock | 1853 | $29.96 | 53,707.3700 | 123,905,000 | 3.34% | 0.00% |
| Jan. 6, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | S | Common Stock | 2816 | $33.81 | 55,560.3700 | 123,905,000 | 4.82% | 0.00% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | A | Common Stock | 25445 | $0.00 | 58,376.3700 | 118,678,000 | 77.27% | 0.02% |
| Jan. 16, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | A | Stock Option (Right to Buy) | 37000 | $66.30 | 37,000.0000 | 118,678,000 | 9999.99% | 0.03% |
| Jan. 4, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | S | Common Stock | 2751 | $60.05 | 32,931.3700 | 118,678,000 | 7.71% | 0.00% |
| Jan. 3, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | A | Stock Option (Right to Buy) | 49000 | $50.28 | 49,000.0000 | 106,114,000 | 9999.99% | 0.05% |
| Jan. 3, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Baumal Caroline | Chief Medical Officer | A | Common Stock | 35549 | $0.00 | 35,682.3700 | 106,114,000 | 9999.99% | 0.03% |